The simple, optional features of Bayer's CONTOUR^® blood glucose meter were shown to help insulin users achieve success in changing testing behaviors.^{* 2}

EASY TO LEARN AND USE

• Insert the test strip and test your blood glucose level — it's that simple

• Identify trouble spots with personalized HI/LO target range and summary of your blood glucose test results

• See effect of food choices on your blood glucose levels with pre-meal and post-meal markers³

• No Coding™ technology eliminates inaccurate blood glucose test results due to miscoding

• More tracking knowledge with 7-, 14- and 30-day averages of your blood glucose levels

• Fast, 5-second test time with tiny sample size — 0.6 μL

^*In a Bayer study compared to those using only the basic meter features.

References:

1 Harrison B, Leazenby C, Halldorsdottir S. accuracy of the CONTOUR^®  blood glucose monitoring system. J Diabetes Sci Technol. 2011;5(4):1009-1013.
2. Bergenstal RM, Bode B, Tamler R, et al. ACT: Actions with the^® blood glucose meter and behaviors in frequent testers [abstract 2063-P0]. Diabetes. 2010;59 (suppl 1):A5 40. Study sponsored by Bayer.
3 IDF. Guideline for management of postmeal glucose. 2007.

Learning to use your CONTOUR^® meter? Check out the videos and user guides below for product demonstrations and step-by step instructions for your CONTOUR^® meter.

User Guide

ENGLISH > SPANISH >

Quick Guide

ENGLISH > SPANISH >

Easy for patients to learn and test

CONTOUR^® strip technology ensures user accuracy.^1,2

No Coding™ technology

PRE- AND POST-MEAL MARKERS

CONTOUR^®'s pre- and post-meal markers and test reminders, with 7-, 14-, and 30-day averages, help your patients understand and monitor their PPG. PPG is an important glycemic target and contributes significantly to overall glycemia in patients with an A1C level below 9.3%.^1-5

PROGRAMMABLE HI/LO SETTINGS

Personalized target ranges and test result summary help patients identify trouble spots such as hypoglycemia. The ADA guidelines recommend that for non-pregnant adults glycemic goals should be individualized based on:⁶

• Duration of diabetes

• Age/life expectancy

• Comorbid conditions

• Known CVD or advanced microvascular complications

• Hypoglycemia unawareness

• Individual patient considerations

With the CONTOUR® programmable HI/LO settings, your patients' meters can be personalized to account for their unique monitoring needs

PROVEN ACCURACY

With 99.3% accuracy, the CONTOUR® meter meets International Organization for Standardize requirements.⁸CONTOUR^® features were designed to reduce sources of error:

• No Coding™ technology

• No interference with maltose, galactose, oxygen, or many other common interfering substances^†

• Automatic hematocrit correction^‡

• CONTOUR® meter delivered 100% of results in clinically safe Zones A and B in a Clarke Error Grid analysis⁸

• FreeStyle Lite® and Accu-Chek® Aviva showed results in Zone D⁸

References:

• 1 AACE. Endocr Pract. 2007;13(suppl):3-68.

• 2 IDF. Guideline for management of postmeal glucose. 2007.

• 3 Monnier L et al. Diabetes Care. 2003;26:881-885.

• 4 Monnier L, Colette C. Curr Diab Rep. 2008;8:368-374.

• 5 Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the northern California kaiser permanente diabetes registry. Am J Med. 2001;111:1–9.

• 6 ADA. Diabetes Care. 2010;33:S11-S61.

• 7 Bayer's CONTOUR^® test strips with GDH-FAD chemistry cross-react with xylose. Do not use CONTOUR^® test strips during or shortly after a xylose absorption test.

• † Such as ascorbic acid and acetaminophen.

• ‡ From 0% to 70%. 8. Data on file, Bayer Healthcare Diabetes Care.

• 8 Data on file, Bayer Healthcare Diabetes Care.